Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of October 4, 2026.

Dr. Amilcar Gabriel Rodriguez Melendez, MD

Individual provider Pediatric Dermatology Physician · NPI 1174817449

Dr. Amilcar Gabriel Rodriguez Melendez, MD practises Dermatology in Ponce, Puerto Rico. Graduated from Ponce School of Medicine in 2011, 15 years ago. Practices as a sole proprietor and accepts Medicare assignment. Licensed in Puerto Rico.

Years since qualifying
15
Trained at
Ponce School of Medicine
Licensed in
PR
In the registry since
2011
Specialties on file
3
What do these letters mean?
MD — Doctor of Medicine
A physician who completed allopathic medical school.

See every abbreviation used in this directory →

Practice location Address may be wrong

The ZIP code does not match the city and state on this record. Call before visiting.

917 Ave Tito Castro Ste 802 Torre Medica San Lucas
Ponce, PR 00716
Phone: (787) 505-4555
Fax: (787) 507-4555

Specialties & licences

Dermatology Physician (primary) Taxonomy 207N00000X · Licence 19313 (PR)
Pediatric Dermatology Physician Taxonomy 207NP0225X · Licence 19313 (PR)
Procedural Dermatology Physician Taxonomy 207NS0135X · Licence 19313 (PR)

Record details

NPI number1174817449
Entity typeIndividual (Type 1)
GenderMale
Credentials MD
Sole proprietorYes
NPI enumeratedJune 4, 2011
Last updated in NPPESAugust 21, 2023
Certification dateAugust 17, 2023

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyDERMATOLOGY
Medical schoolPONCE SCHOOL OF MEDICINE
Graduated 2011 (15 years in practice)
Accepts Medicare assignment Yes — accepts the Medicare-approved amount

Procedures

From CMS Care Compare, which counts the procedures a clinician billed to Original Medicare and Medicare Advantage over a recent 12-month period. CMS reports a fixed list of common procedures, so this is not everything the clinician does. Counts of 10 or fewer are given as a range, because CMS withholds small numbers.

Removal of skin lesions 62 times · 73rd percentile
Skin biopsy 52 times · 69th percentile
Melanoma (skin cancer) excision 1–10 times

The percentile compares how often this clinician performed the procedure with other clinicians who performed it, as CMS calculates it. It measures volume, not outcomes or skill.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $749 10 payments · a meal or drink at a meeting or visit, not a fee
Education $99 1 payment · educational material or training, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.